|
Re: Private placement
|
6
|
Resverlogix Corp.
|
Aug 30, 2018 09:54AM
|
|
Re: Probability of Phase 3 trial success
|
4
|
Resverlogix Corp.
|
Jun 24, 2019 12:07PM
|
|
Re: Progress
|
1
|
Resverlogix Corp.
|
Jul 28, 2020 07:49PM
|
|
Re: Progress
|
3
|
Resverlogix Corp.
|
Jul 25, 2020 11:25AM
|
|
Re: Properly powered? What does the FDA think?
|
|
Resverlogix Corp.
|
May 11, 2018 03:21AM
|
|
Re: Properly powered? What does the FDA think?
|
4
|
Resverlogix Corp.
|
May 11, 2018 04:46PM
|
|
Re: Prospects for resverlogix
|
8
|
Resverlogix Corp.
|
Jul 15, 2020 12:21PM
|
|
Re: Prostate Trial
|
6
|
Zenith Epigenetics
|
Apr 24, 2020 10:50AM
|
|
Re: Proxy materials received in the US
|
1
|
Resverlogix Corp.
|
Aug 13, 2018 08:03PM
|
|
Re: Proxy's
|
1
|
Resverlogix Corp.
|
Sep 28, 2019 08:46PM
|
|
Re: Published 8 days ago; review article out of Qatar Univ.
|
4
|
Resverlogix Corp.
|
Feb 16, 2024 08:07PM
|
|
Re: Q1- March 31, 2022 on SEDAR
|
3
|
Resverlogix Corp.
|
May 20, 2022 05:24PM
|
|
Re: Q1- March 31, 2022 on SEDAR
|
5
|
Resverlogix Corp.
|
May 21, 2022 11:36PM
|
|
Re: Q1- March 31, 2022 on SEDAR
|
6
|
Resverlogix Corp.
|
May 22, 2022 01:44PM
|
|
Re: Q1- March 31, 2022 on SEDAR
|
9
|
Resverlogix Corp.
|
May 22, 2022 01:53PM
|
|
Re: Q3 Events updated
|
4
|
Resverlogix Corp.
|
Aug 10, 2017 11:47PM
|
|
Re: Que sera sera....
|
4
|
Resverlogix Corp.
|
Mar 31, 2018 04:11AM
|
|
Re: Que sera sera....
|
2
|
Resverlogix Corp.
|
Mar 31, 2018 02:46PM
|
|
Re: Que sera sera....
|
3
|
Resverlogix Corp.
|
Apr 03, 2018 06:05AM
|
|
Re: Que sera sera....
|
4
|
Resverlogix Corp.
|
Mar 30, 2018 01:50PM
|
